Ye Shen

Ye Shen

Auto-generated profile, based on publicly available information

Ye Shen

University of Georgia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
YGYang Ge
Yang Ge
LMLeonardo Martinez
Leonardo Martinez
Shengzhi SunShengzhi Sun
Shengzhi Sun
ZCZhiping Chen
Zhiping Chen
FZFeng Zhang
Feng Zhang
YSYe Shen
Ye Shen
SARS-CoV-2 is a novel beta coronavirus originating in late 2019.1,2 By the end of 2020, hundreds of millions of individuals had acquired COVID-19 infection, leading to the disability and death of millions3 and a substantial indirect influence on other diseases.4 COVID-19 is characterized by high transmission rates, at times leading to large outbreaks, mostly in indoor congregate settings.5-7 However, many aspects of COVID-19 transmission remain to be fully understood,8,9 and there is uncertainty regarding the effectiveness of public health strategies that attempt to prevent COVID-19 transmission.8,9

2 August 2020 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
QLQiao Liu
Qiao Liu
PLPeng Lu
Peng Lu
YSYe Shen
Ye Shen
Changwei LiChangwei Li
Changwei Li
JWJianming Wang
Jianming Wang
LMLeonardo Martinez
Leonardo Martinez
The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015–2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.

5 April 2024 in eLife
Verified
Journal Article
Open access
YZYuchen Zhang
Yuchen Zhang
YSYitang Sun
Yitang Sun
QYQi Yu
Qi Yu
SSSuhang Song
Suhang Song
JBJ. Thomas Brenna
J. Thomas Brenna
Kaixiong YeKaixiong Ye
Kaixiong Ye
Background: Circulating omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) have been associated with various chronic diseases and mortality, but results are conflicting. Few studies examined the role of omega-6/omega-3 ratio in mortality.Methods: We investigated plasma omega-3 and omega-6 PUFAs and their ratio in relation to all-cause and cause-specific mortality in a large prospective cohort, the UK Biobank. Of 85,425 participants who had complete information on circulating PUFAs, 6461 died during follow-up, including 2794 from cancer and 1668 from cardiovascular disease (CVD). Associations were estimated by multivariable Cox proportional hazards regression with adjustment for relevant risk factors.Results: Risk for all three mortality outcomes increased as the ratio of omega-6/omega-3 PUFAs increased (all Ptrend <0.05). Comparing the highest to the lowest quintiles, individuals had 26% (95% CI, 15–38%) higher total mortality, 14% (95% CI, 0–31%) higher cancer mortality, and 31% (95% CI, 10–55%) higher CVD mortality. Moreover, omega-3 and omega-6 PUFAs in plasma were all inversely associated with all-cause, cancer, and CVD mortality, with omega-3 showing stronger effects.Conclusions: Using a population-based cohort in UK Biobank, our study revealed a strong association between the ratio of circulating omega-6/omega-3 PUFAs and the risk of all-cause, cancer, and CVD mortality.Funding: Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under the award number R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

1 July 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
NKNupur Kittur
Nupur Kittur
CCCarl H. Campbell
Carl H. Campbell
SBSue Binder
Sue Binder
YSYe Shen
Ye Shen
RWRyan E. Wiegand
Ryan E. Wiegand
DCDaniel G. Colley
Daniel G. Colley
The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) conducted large field studies on schistosomiasis control and elimination in Africa. All of these studies, carried out in low-, moderate-, and high-prevalence areas, resulted in a reduction in prevalence and intensity of Schistosoma infection after repeated mass drug administration (MDA). However, in all studies, there were locations that experienced minimal or no decline or even increased in prevalence and/or intensity. These areas are termed persistent hotspots (PHS). In SCORE studies in mediumto high-prevalence areas, at least 30% of study villages were PHS. There was no consistent relationship between PHS and the type or frequency of intervention, adequacy of reported MDA coverage, and prevalence or intensity of infection at baseline. In a series of small studies, factors that differed between PHS and villages that responded to repeated MDA as expected included sources of water for personal use, sanitation, and hygiene. SCORE studies comparing PHS with villages that responded to MDA suggest the potential for PHS to be identified after a few years of MDA. However, additional studies in different social-ecological settings are needed to develop generalizable approaches that program managers can use to identify and address PHS. This is essential if goals for schistosomiasis control and elimination are to be achieved.

10 March 2020 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
YSYe Shen
Ye Shen
CLChangwei Li
Changwei Li
HDHongjun Dong
Hongjun Dong
ZWZhen Wang
Zhen Wang
LMLeonardo Martinez
Leonardo Martinez
GXGuozhang Xu
Guozhang Xu
Background: Much remains unknown about COVID-19 transmission. We evaluated potential transmission routes from two community COVID-19 outbreaks. Methods: In the first outbreak, 126 passengers took two buses (59 from Bus #1 and 67 from #2) on a 100-minute round trip to attend a 150-minute worship event. The source patient was a passenger on Bus #2. We compared risks of COVID-19 among individuals taking Bus #1 (n=60) and Bus #2 (n=67), and among all other individuals (n=172) attending the worship event. We also divided seats on the exposed bus into high- and low-risk zones according to distance to the source patient and compared COVID-19 risks in each zone. The second outbreak occurred among 30 trainees attending a 3-day workshop in several conference rooms. In both buses and conference rooms, central air-conditioners were in indoor re-circulation mode. Results: In the first COVID-19 outbreak, passengers in Bus #2 had a 41.5 (95% confidence interval [CI]: 2.6–669.5) times higher risk of getting COVID-19 compared to those in Bus #1, and 11.4 (95% CI: 5.1–25.4) times higher risk compared to all other individuals attending the worship event. Within Bus #2, passengers in high-risk zones had moderately, but non-significantly, higher risk for COVID-19 compared to those in the low-risk zones. In the second outbreak, the overall attack rate was 48.3%. Conclusion: Airborne spread of COVID-19 appears to at least partially explain the high attack rates in the exposed bus and conference rooms. Future efforts at prevention and control must consider the potential for airborne spread of the virus.

17 October 2019 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
YSYe Shen
Ye Shen
MSMeng-Hsuan Sung
Meng-Hsuan Sung
CKCharles H King
Charles H King
SBSue Binder
Sue Binder
NKNupur Kittur
Nupur Kittur
DCDaniel G. Colley
Daniel G. Colley
Background: Some villages, labeled “persistent hotspots (PHS),” fail to respond adequately in regard to prevalence and intensity of infection to mass drug administration (MDA) for schistosomiasis. Early identification of PHS, for example, before initiating or after 1 or 2 years of MDA could help guide programmatic decision making.Methods: In a study with multiple rounds of MDA, data collected before the third MDA were used to predict PHS. We assessed 6 predictive approaches using data from before MDA and after 2 rounds of annual MDA from Kenya and Tanzania.Results: Generalized linear models with variable selection possessed relatively stable performance compared with tree-based methods. Models applied to Kenya data alone or combined data from Kenya and Tanzania could reach over 80% predictive accuracy, whereas predicting PHS for Tanzania was challenging. Models developed from one country and validated in another failed to achieve satisfactory performance. Several Year-3 variables were identified as key predictors.Conclusions: Statistical models applied to Year-3 data could help predict PHS and guide program decisions, with infection intensity, prevalence of heavy infections (≥400 eggs/gram of feces), and total prevalence being particularly important factors. Additional studies including more variables and locations could help in developing generalizable models.